Atwood & Palmer Inc Eli Lilly & CO Transaction History

Atwood & Palmer Inc

$1.45 Billion
Q3 2024

A detailed history of Atwood & Palmer Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Atwood & Palmer Inc holds 512 shares of LLY stock, worth $406,599. This represents 0.03% of its overall portfolio holdings.

Number of Shares

512

Previous 509 0.59%

Holding current value

$406,599

Previous $460,000 1.52%

% of portfolio

0.03%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$772.14 - $960.02 $2,316 - $2,880	3 Added 0.59%	512 $453,000
Q1 2024 Apr 10, 2024	BUY	$592.2 - $792.28 $7,106 - $9,507	12 Added 2.41%	509 $395,000
Q4 2023 Jan 12, 2024	BUY	$525.19 - $619.13 $53,569 - $63,151	102 Added 25.82%	497 $289,000
Q2 2022 Jul 21, 2022	SELL	$278.73 - $327.27 $1,393 - $1,636	-5 Reduced 1.25%	395 $128,000
Q1 2022 Apr 29, 2022	SELL	$234.69 - $291.66 $11,734 - $14,583	-50 Reduced 11.11%	400 $115,000
Q4 2021 Jan 24, 2022	BUY	$224.85 - $279.04 $2,248 - $2,790	10 Added 2.27%	450 $124,000
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $8,864 - $10,908	40 Added 10.0%	440 $102,000
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $18,055 - $23,354	100 Added 33.33%	400 $92,000
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $32,864 - $42,544	-200 Reduced 40.0%	300 $56,000
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $52,184 - $69,052	400 Added 400.0%	500 $84,000
Q4 2019 Feb 05, 2020	SELL	$106.92 - $132.43 $57,095 - $70,717	-534 Reduced 84.23%	100 $13,000
Q3 2019 Oct 21, 2019	BUY	$106.79 - $116.16 $10,679 - $11,616	100 Added 18.73%	634 $71,000
Q2 2019 Jul 17, 2019	SELL	$110.79 - $129.32 $11,079 - $12,932	-100 Reduced 15.77%	534 $59,000
Q1 2019 Apr 23, 2019	SELL	$111.31 - $131.02 $11,131 - $13,102	-100 Reduced 13.62%	634 $82,000
Q4 2018 Feb 01, 2019	BUY	$105.9 - $118.64 $56,550 - $63,353	534 Added 267.0%	734 $85,000
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $23,598 - $27,856	-318 Reduced 61.39%	200 $15,000
Q2 2017 Aug 08, 2017	BUY	N/A	518	518 $43,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwood & Palmer Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atwood & Palmer Inc with notifications on news.

Account

Atwood & Palmer Inc Eli Lilly & CO Transaction History